We started Seer to solve accessibility challenges in neurodiagnostics.

Video-EEG-ECG testing is the undisputed gold standard for diagnosing and characterising epilepsy and related conditions. A significant portion of the population will experience an event that requires testing to understand the cause and treatment pathway.

Today, there is a drastic unmet need for video-EEG-ECG testing globally. Limited access can result in years-long delays in getting answers and contributes to the 30% misdiagnosis rate in epilepsy, and one-third of people with epilepsy never get control of their seizures. This has created a dire situation for people experiencing seizures and spells.

My co-founders and I started Seer to solve these major issues. Seer is here to empower physicians and people living with epilepsy to make data-informed decisions that will enable them to live fuller, happier lives.

Continent-scale proof of concept

Australia is Seer’s home market. Since 2017, we’ve helped more than 15,000 Australians reach accurate diagnosis, fast-tracking their pathway to effective condition management.

Through this process, we have diverted more than 246 years of inpatient hospital bed years to at-home diagnostic care, freeing up those beds for people who require medical treatments and interventions.

Seer Medical products

Seer Home - Monitoring Device for Neurology Practice